Market Access News | pharmaphorum

News

Sanofi in final stages of negotiation in sale of generics ar...

Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International.

Market Access

NICE okays Roche rare lung cancer drug after price cut

Alecensa has aced Pfizer's rival in head-to-head trial

News

Mylan to market Lupin's Enbrel biosimilar outside US

Lupin's biosimilar is under review in EU

News

NICE okays NHS funding for MS and eczema drugs

The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.

News

Industry urges EU to scrap national HTA bodies

Influential EU committee discusses proposals today

News

NICE says 'no' to Roche's Perjeta after breast cancer surger...

NICE consulting on first draft decision

Sanofi in final stages of negotiation in sale of generics ar...

NICE okays Roche rare lung cancer drug after price cut

Mylan to market Lupin's Enbrel biosimilar outside US

NICE okays NHS funding for MS and eczema drugs

Industry urges EU to scrap national HTA bodies

NICE says 'no' to Roche's Perjeta after breast cancer surger...

Quartet of biotechs join Nasdaq after stellar IPOs

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks